Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degenerati…

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no ...

What we know about rumor US used sonic weapon during Venezuela attack

After the U.S. removed Venezuela President Nicolás Maduro from power on Jan. 3, 2026, a rumor began to spread that as part of ...